Tag: Myopia Control

EssilorLuxottica today announced the U.S. Food and Drug Administration (FDA) has granted market authorization for its Essilor Stellest lens using the De Novo pathway. This follows the product’s earlier recognition with the FDA granting designation as a Breakthrough Device in 2021. The Essilor Stellest lens is the first-ever FDA market authorized spectacle lens clinically proven to slow myopia progression in children1,2.

The Myopia Collective represents a significant step forward in the fight against childhood myopia. By joining this initiative, eye care professionals can access valuable resources, connect with like-minded colleagues, and lead the charge in their communities.

Welcome to the February 2024 edition of EyeCare Shenanigans, where the future of optometry comes into sharp focus. This month, Dr. Jeffrey Fardink and...

https://youtu.be/8MR8lIuOM5s

What is myopia control? How is the best resources for myopia control? How does one make myopia control mainstream? Dr. David Kading shares his vision on into myopia control's impact on vision.

Top Optometry podcasts by for all eye care professionals. The Defocus Media Optometry Podcast Network features new leaders and innovators in the eye care world each week, inspiring young doctors to think outside the confines of traditional optometry, explore new products and learn about new niche practice opportunities.

FOR IMMEDIATE RELEASE  Partnership to focus on myopia education and train eye care professionals to fit new lenses at Treehouse Eyes locations across the U.S. BOULDER,...

We’re in the middle of a public health crisis, even as COVID-19 numbers improve and life begins to return to normal for millions of...

We celebrated #MyopiaAwarenessWeek by sharing the mission and actions of the Global Myopia Awareness Coalition and what is being done to bring public awareness to myopia...

We can’t truly start 2020 until we’ve teamed up with Dr. Jackie Garlich of 2020 Glance to break down the biggest new additions in pharmaceuticals and...